Online still woefully underfunded in pharma
Datamonitor hit the nail right on the head with their report on eHealth Insights for the pharma industry. Since speed of implementation is a competitive advantage one would have to wonder when the lights are going to go on inside pharma marketers heads? One reader recently posted a comment that "the reason for pharma not embracing new media is not because of ROI but because of the legal issues involved". That myopic thinking is one of the primary reasons that pharma marketers are stuck in the past and refuse to embrace online media.

According to another report from eMarketer, pharma is
planning to increase spending online but in a puzzle
the increase in spending for online still only
represents 5% of the total budget? This means that
either marketers are expecting DTC budgets to
increase (not likely but with new products this is a
possibility) and that the Web will never receive
enough money for pharma to truly explore new media
options. By the way those marketers that do extremely
well on the Web were spending 20% of their budgets
online and some are now going to expand that number
to 40-50% of dollars allocated for online.
In planned changes for spending in pharma websites
the number one planned increase is Web sites. Well if
done correctly a branded and unbranded Website could
cost $2-$3 million including research and user
testing. The next line item, search engine keywords,
is probably the area where pharma wastes more and
more money. Like I have written here before clicks
don't mean a thing to me it is "cost per targeted
action" as too many people will click come to your
home page and leave on your home page.


